Peptide Database
Showing 13 of 58 peptides
| Category | FDA Status | |||
|---|---|---|---|---|
| CJC-1295 with DACLong-acting GH elevation, less frequent dosing, sustained IGF-1 increase | Growth Hormone | Phase II | Not Approved | 2 trial pubs1 registered29 PubMed references |
| CJC-1295/IpamorelinGrowth hormone release, body composition, anti-aging | Growth Hormone | Phase II | Not Approved | N/A trial pubs2 registered0 PubMed references |
| Follistatin-344Myostatin inhibition, muscle growth, muscular dystrophy research | Growth Hormone | Phase I | Not Approved | 0 trial pubs1 registered5 PubMed references |
| GHRP-2Potent GH release, appetite stimulation, body composition | Growth Hormone | Animal | Not Approved | 56 trial pubs0 registered203 PubMed references |
| GHRP-6Growth hormone release, appetite stimulation, gut motility | Growth Hormone | Animal | Not Approved | 43 trial pubs0 registered632 PubMed references |
| HexarelinMost potent GHRP, cardioprotective effects, GH secretion research | Growth Hormone | Animal | Not Approved | 58 trial pubs0 registered288 PubMed references |
| HGHGrowth hormone deficiency, anti-aging, body composition | Growth Hormone | Approved | Approved | 946 trial pubs812 registered9,318 PubMed references |
| IGF-1 LR3Muscle protein synthesis, extended half-life IGF-1, anabolic | Growth Hormone | Animal | Not Approved | 0 trial pubs0 registered10 PubMed references |
| IpamorelinSelective growth hormone release, body composition, sleep quality | Growth Hormone | Phase II | Not Approved | 2 trial pubs2 registered46 PubMed references |
| MK-677 (Ibutamoren)Oral GH secretagogue, sleep quality, muscle preservation | Growth Hormone | Phase III | Not Approved | 19 trial pubs8 registered114 PubMed references |
| SermorelinGrowth hormone stimulation, sleep quality, anti-aging | Growth Hormone | Approved | Not Approved | 0 trial pubs27 registered22 PubMed references |
| TesamorelinVisceral fat reduction, growth hormone deficiency, lipodystrophy | Growth HormoneWeight Loss | Approved | Approved | 23 trial pubs24 registered87 PubMed references |
| TrevogrumabMyostatin blocker, anti-muscle-loss for GLP-1 users, Regeneron antibody | Growth Hormone | Phase II | Investigational | 0 trial pubs1 registered2 PubMed references |